Hostname: page-component-7c8c6479df-27gpq Total loading time: 0 Render date: 2024-03-29T17:39:41.717Z Has data issue: false hasContentIssue false

Ephedrine Psychosis Rediscovered

Published online by Cambridge University Press:  02 January 2018

Andrew M. Whitehouse*
Affiliation:
Addenbrooke's Hospital, Formerly Registrar, Royal Edinburgh Hospital
Janice M. Duncan
Affiliation:
Royal Edinburgh Hospital and the State Hospital, Carstairs. Formerly Senior Registrar, Royal Edinburgh Hospital
*
Department of Psychiatry, Addenbrooke's Hospital, Hills Road, Cambridge CB2 2QQ

Extract

The use of ephedrine for medicinal purposes dates back over 5000 years, when native Chinese physicians Ma Huang in the late 1800s, but was considered too toxic for clinical use; it was rediscovered by Chen & Schmidt (1930), who demonstrated its sympatho mimetic action and introduced it into Western medicine, where it was found to be a big improvement on adrenaline in the treatment of asthma. That the structure of ephedrine is very similar to that of amphetamine is not a coincidence, since Alles (1933) synthesised the latter as a synthetic substitute for ephedrine.

Type
Brief Reports
Copyright
Copyright © 1987 The Royal College of Psychiatrists 

Access options

Get access to the full version of this content by using one of the access options below. (Log in options will check for institutional or personal access. Content may require purchase if you do not have access.)

References

Alles, G. A. (1933) The comparative physiological actions of dl-β phenylisopropylamines. I. Pressor effect and toxicity. Journal of Pharmacology and Experimental Therapeutics, 47,339354.Google Scholar
Chapple, P. A. L. (1965) New drugs of addiction (letter). British Medical Journal, 2, 108.CrossRefGoogle Scholar
Chen, K. K. & Schmidt, C. F. (1930) Ephedrine and related substances. Medicine, 9; 117.Google Scholar
Connell, P. H. (1958) Amphetamine Psychosis (Maudsley Monographs) London: Oxford University Press.Google Scholar
Davidson, K. & Bagley, C. R. (1969) Schizophrenia-like psychoses associated with organic disorders of the central nervous system: a review of the literature. In Current Problems in Neuropsychiatry (ed. R. N. Herrington). London: British Journal of Psychiatry Special Publication No. 4.Google Scholar
Dougherty, R. J. (1982) Pseudo-speed, look alikes or pea shooters. New York State Journal of Medicine, 1, 7475.Google Scholar
Ellinwood, E. H. (1969) Amphetamine psychosis: a multi- dimensional process. Seminars in Psychiatry, 1, 208226.Google Scholar
Herridge, C. F. & A'Brook, M. F. (1968) Ephedrine psychosis. British Medical Journal, 2, 160.Google Scholar
Kendell, R. E. (1975) The Role of Diagnosis in Psychiatry, Oxford: Blackwell.Google Scholar
Martin, W. R., Sloan, J. W., Sapira, J. P. & Jasinski, D. R. (1971) Physiologic, subjective and behavioural effects of amphetamine, methamphetamine, ephedrine, phenmetrazine and methylphenidate in man. Clinical Pharmacology and Therapeutics, 12, 245258.Google Scholar
Otto, K. R. & Nause, R. (1980) Paranoid hallucinatory psychosis following chronic Asthmolytan. Psychiatrie Neurologie und medizinische Psychologie, 32, 492495.Google Scholar
Scheid, W. (1962) Die Lehre von den ‘exogenen Reaktionstypen’ vor einem halben Jahrundert und Heute. In Psychopathologie Heute (ed. H. Kranz), Stuttgart.Google Scholar
Siegel, R. A. (1980) Cocaine substitutes (letter) New England Journal of Medicine, 302, 14, 817818.Google Scholar
Slater, E. (1959) Book review. British Medical Journal, i, 488.Google Scholar
Wieck, H. (1956) Zur klinik der sogenannten symptomatischen Psychosen. Deutesche medizinische Wochenschrift, 81, 13451349.CrossRefGoogle Scholar
Wooten, M. R., Khangure, M. S. & Murphy, M. J. (1983) Intracerebral haemorrhage and vasculitis related to ephedrine abuse. Annals of Neurology, 13, 337340.CrossRefGoogle ScholarPubMed
Submit a response

eLetters

No eLetters have been published for this article.